Lupus & Connective Tissue Diseases
Feature
The Appendix: Is It ’Useless,’ or a Safe House and Immune Training Ground?
It turns out the appendix, as easy to dismiss as it is to remove, may have a vital purpose after all, including protecting us from...
Latest News
Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related Disease
Inebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
From the Journals
Cortisol Test Confirms HPA Axis Recovery from Steroid Use
A test that measures serum cortisol levels to predict recovery of the hypothalamic-pituitary-adrenal axis in patients tapering down chronic...
From the Journals
Greater Awareness Urged for Important, Overlooked Neuropsychiatric Symptoms of Lupus
Findings from a qualitative study suggested a greater need for rheumatology clinicians to initiate discussions with patients about...
From the Journals
Key Risk Factors for Hydroxychloroquine Retinopathy Described in Large Study
Including over 4670 patients, this is “the largest cohort study to date looking specifically at the association of [HCQ] retinopathy with risk...
News from the FDA/CDC
Belimumab Autoinjector Approved for Pediatric Lupus
This enables at-home administration of the medication, which was previously available only via intravenous infusion.
Latest News
‘Big Breakthrough’: New Low-Field MRI Is Safer and Easier
New study describes ultra low–field MRI to allow for whole-body scanning.
Rheum for Action
Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
Legislative or regulatory action is unlikely to address the current negative reimbursement situation for office-based infusion of certain...
Conference Coverage
Why Incorporating Obstetric History Matters for CVD Risk Management in Autoimmune Diseases
A history of pregnancy complications can put women with autoimmune disease at a higher risk for CVD. Prophylaxis during pregnancy may avoid those...
From the Journals
bDMARDs Preserve Renal Function in Most Patients With AA Amyloidosis
Biologic DMARD therapy preserved renal function in 75% of patients with AA amyloidosis, but the remaining 25% progressed to end-stage renal...
From the Journals
Diagnosing Giant Cell Arteritis Using Ultrasound First Proves Accurate, Avoids Biopsy in Many Cases
In a prospective study, all patients diagnosed with giant cell arteritis using ultrasound maintained their diagnosis for up to 2 years of follow-...